Accessibility Statement Skip Navigation
  • Назад к Международным сайтам
  • +44 (0)20 7454 5110
  • GDPR
  • Журналисты
  • Запросить дополнительную информацию
PR Newswire: news distribution, targeting and monitoring
  • Новости
  • Продукция
  • Обратная связь
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Запросить дополнительную информацию
      • Телефон

      • +44 (0)20 7454 5110 от 8 AM - 5 PM GMT

      • Свяжитесь с нами
      • Свяжитесь с нами

        +44 (0)20 7454 5110
        от 8 AM - 5 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • Новости
    • Продукция
    • Обратная связь
      • Запросить дополнительную информацию
      • Журналисты
      • GDPR
      • General Enquiries
      • Request a Demo
      • Editorial Bureaus
      • Partnership
      • Media Enquiries
      • Worldwide Offices
      • Запросить дополнительную информацию
      • Журналисты
      • GDPR

      Meet Zent2U at Virtual CPhi Festival of Pharma 2020

      Zentiva Logo (PRNewsfoto/Zentiva)

      Информация предоставлена

      Zentiva

      12 окт, 2020, 06:00 GMT

      Поделиться этой статьей

      Поделиться этой статьей


      PRAGUE, Oct. 12, 2020 /PRNewswire/ -- The B2B Zent2U platform, powered by Zentiva, attends the online CPhI Festival of Pharma. The team will showcase its R&D pipeline assets for strategic partnerships through Zent2u. During this virtual congress, Zent2U representatives will meet with strategic stakeholders to discuss future collaboration leading to partnerships for success.

      Continue Reading
      Zent2U Logo
      Zent2U Logo

      "Building win-win partnerships is at the heart of our growth story. Our strategic Zent2U platform, powered by Zentiva, is a leader in the field of Urology, Cardio, Pain, and Oncology. Our technologies specialize in hormones, sterile (eyedrops, ampoules, vials, ointments) and pellet, making us a strong player" said Thomas Koene, Head of Strategic Growth Partnerships, Zentiva. "Our company also offers Value Added Medicines in Oncology for co-development and strategic out-licensing. Besides, two of them are in an advanced stage of development and are ready to be further propelled".

      About Zentiva

      Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague and Bucharest - Zentiva strives to be the champion of branded generic medicines and OTC products in Europe to better support people's daily healthcare needs.

      At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. Learn more at www.Zent2u.com.  

      Meet the Zent2U Team:
      Thomas Koene – Head of Strategic Growth Partnerships
      Email: [email protected]  

      Katerina Mala – Pharma Sales Manager
      Mobile: +420775155771 / Email: [email protected]  

      Theo Zainea -  Key Account Manager B2B
      Mobile: +40737717843 / Email: [email protected]  

      Tomas Pilarcik - Key Account Manager B2B
      Mobile: +420724909254 / Email: [email protected]  

      Logo: https://mma.prnewswire.com/media/788903/Zentiva_Logo.jpg

      Logo: https://mma.prnewswire.com/media/1310370/Zent2U_Logo.jpg

      Media Contact: 
      Mounira Lemoui
      Head of Communications
      ZENTIVA GROUP, a.s. 
      U kabelovny 529/16, Dolní Měcholupy, 102 00 Prague 10  
      Cell: (+420) 727 873 159  
      E-mail: [email protected]

      Modal title

      Способы связи с PR Newswire

      • +44 (0)20 7454 5110
        от 8 AM - 5 PM GMT

      Все сайты

      • APAC
      • APAC - Традиционный китайский
      • Азия
      • Бразилия
      • Канада
      • Чешский
      • Дания
      • Финляндия
      • Франция
      • Германия

       

      • Индия
      • Indonesia
      • Израиль
      • Италия
      • Мексика
      • Средний Восток
      • Средний Восток - арабский
      • Нидерланды
      • Норвегия
      • Польша

       

      • Португалия
      • Россия
      • Словакия
      • Испания
      • Швеция
      • Великобритания
      • Соединенные Штаты

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921
      Все сайты
      • Азия
      • Бразилия
      • Канада
      • Чешский
      • Дания
      • Финляндия
      • Франция
      • Германия
      • Индия
      • Израиль
      • Италия
      • Мексика
      • Middle East
      • Нидерланды
      • Норвегия
      • Польша
      • Португалия
      • Россия
      • Словакия
      • Испания
      • Швеция
      • Великобритания
      • Соединенные Штаты
      +44 (0)20 7454 5110
      от 8 AM - 5 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • Cookie Settings
      Copyright © 2026 Cision US Inc.